Solid Tumor Clinical Trials

A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1109 clinical trials
Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors

TQB3915 is a selective estrogen receptor covalent antagonist, by covalently binding to estrogen receptor, by changing the conformation of ERα, blocking intracellular signal transmission, thereby inhibiting the growth of tumor cells.

  • 0 views
  • 29 Jun, 2022
  • 1 location
A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

Nivolumab in participants with select advanced solid tumors.

  • 0 views
  • 30 Jun, 2022
  • 3 locations
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors

The primary objective of the study is to determine the recommended phase 2 dose (RP2D) of Debio 0123 when administered in combination with carboplatin in participants with advanced solid tumors

  • 16 views
  • 12 Jul, 2022
  • 4 locations
Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

activity profile of the RP2D of OBI-999 in patients with advanced solid tumors.

  • 0 views
  • 21 Jul, 2022
  • 4 locations
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors (WEE1)

A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid Tumors

  • 0 views
  • 21 Jul, 2022
  • 14 locations
A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors

The purpose of this study is to determine the recommended phase 2 dose (RP2D) regimen(s) of JNJ-78306358 in Part 1 (Dose Escalation) and to determine the safety of JNJ-78306358 at the RP2D regimen(s) in Part 2 (Dose Expansion).

primary cancer
treatment regimen
carcinoma
EGFR
bevacizumab
  • 0 views
  • 23 Jul, 2022
  • 5 locations
  • 7 views
  • 23 Jul, 2022
  • 3 locations
REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors (COMBINE-EGFR-1)

patients with advanced solid tumors Dose Expansion: • To assess the preliminary efficacy of REGN7075 in combination with cemiplimab within selected advanced solid tumor-specific cohorts, as

  • 6 views
  • 21 Jul, 2022
  • 8 locations
Dose Escalation and Expansion Study of SAR444200 in Adult Participants With Advanced Solid Tumors

This is a single group, treatment, Phase 1/Phase 2, open label, multiple cohort, first-in-human study to evaluate safety and efficacy of SAR444200 as a monotherapy or in combination with other anti-cancer agents for participants aged at least 18 years with previously treated metastatic malignancies.

  • 0 views
  • 29 Jul, 2022
  • 1 location
Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors

This is a phase I, multicenter, open-label dose escalation and expansion study to evaluate genakumab alone and in combination with tislelizumab in adult patients with advanced solid malignancies.

  • 0 views
  • 28 Jul, 2022
  • 1 location